Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | +0.58% | -7.64% | -48.67% |
May. 30 | Evercore ISI Cuts Price Target on Editas Medicine to $7 From $15, Maintains In Line Rating | MT |
May. 14 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 28.8M | Sales 2025 * | 24.83M | Capitalization | 428M |
---|---|---|---|---|---|
Net income 2024 * | -223M | Net income 2025 * | -250M | EV / Sales 2024 * | 6.8 x |
Net cash position 2024 * | 232M | Net cash position 2025 * | 95.12M | EV / Sales 2025 * | 13.4 x |
P/E ratio 2024 * |
-1.98
x | P/E ratio 2025 * |
-2.03
x | Employees | 265 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.65% |
Latest transcript on Editas Medicine, Inc.
1 day | +0.58% | ||
1 week | -7.64% | ||
1 month | -4.94% | ||
3 months | -50.62% | ||
6 months | -51.72% | ||
Current year | -48.67% |
Managers | Title | Age | Since |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 22-05-31 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 23-05-16 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 21-09-02 |
David Scadden
BRD | Director/Board Member | 71 | 19-02-05 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 16-07-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.83% | 2 M€ | -25.75% | ||
0.13% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5.2 | +0.58% | 2,429,981 |
24-05-30 | 5.17 | +1.37% | 1,745,214 |
24-05-29 | 5.1 | -4.14% | 1,874,663 |
24-05-28 | 5.32 | -5.51% | 1,716,183 |
24-05-24 | 5.63 | -3.43% | 1,305,042 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.67% | 428M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- EDIT Stock